Representative Bruce Westerman (R-Arkansas) recently sold shares of Danaher Co. NYSE: DHR. In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Danaher stock on April 21st. The trade occurred in the Representative's "FISHER IRA" account.
Representative Bruce Westerman also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of UniCredit OTCMKTS: UNCRY on 4/21/2025.
- Sold $1,001 - $15,000 in shares of CSX NASDAQ: CSX on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Siemens Aktiengesellschaft OTCMKTS: SIEGY on 4/21/2025.
- Sold $1,001 - $15,000 in shares of GSK NYSE: GSK on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 4/21/2025.
- Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 4/21/2025.
- Sold $15,001 - $50,000 in shares of NVIDIA NASDAQ: NVDA on 4/21/2025.
- Sold $1,001 - $15,000 in shares of Chevron NYSE: CVX on 4/21/2025.
Danaher Trading Down 2.1%
Danaher stock opened at $196.60 on Wednesday. The business has a 50 day moving average price of $197.83 and a two-hundred day moving average price of $218.54. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market cap of $140.70 billion, a price-to-earnings ratio of 37.23, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, equities analysts forecast that Danaher Co. will post 7.63 EPS for the current year.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.65%. Danaher's dividend payout ratio (DPR) is 24.85%.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in DHR. Czech National Bank boosted its position in shares of Danaher by 6.4% in the 4th quarter. Czech National Bank now owns 139,378 shares of the conglomerate's stock worth $31,994,000 after purchasing an additional 8,439 shares during the last quarter. Eastover Investment Advisors LLC raised its stake in Danaher by 3.1% during the 4th quarter. Eastover Investment Advisors LLC now owns 6,437 shares of the conglomerate's stock worth $1,478,000 after buying an additional 191 shares during the period. Trust Co. of Toledo NA OH raised its stake in Danaher by 3.0% during the 4th quarter. Trust Co. of Toledo NA OH now owns 36,121 shares of the conglomerate's stock worth $8,292,000 after buying an additional 1,062 shares during the period. Capital Investment Advisors LLC raised its stake in Danaher by 265.5% during the 4th quarter. Capital Investment Advisors LLC now owns 5,640 shares of the conglomerate's stock worth $1,295,000 after buying an additional 4,097 shares during the period. Finally, Agate Pass Investment Management LLC raised its stake in Danaher by 1.3% during the 4th quarter. Agate Pass Investment Management LLC now owns 13,580 shares of the conglomerate's stock worth $3,117,000 after buying an additional 178 shares during the period. 79.05% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the company. Raymond James reiterated a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Citigroup reaffirmed a "buy" rating on shares of Danaher in a report on Monday, April 7th. JPMorgan Chase & Co. dropped their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Finally, Jefferies Financial Group dropped their price target on Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a report on Tuesday, April 22nd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to MarketBeat.com, Danaher has an average rating of "Moderate Buy" and an average price target of $264.40.
Get Our Latest Research Report on DHR
Insider Buying and Selling
In related news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 11.10% of the stock is currently owned by company insiders.
About Representative Westerman
Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas' 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.
Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas' 4th Congressional District. He declared candidacy for the 2026 election.
Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.
Danaher Company Profile
(
Get Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
